Literature DB >> 6614864

Is there an association between ABO blood groups and primary osteoarthrosis of the hip?

J A Lourie.   

Abstract

ABO frequencies are reported in a series of 341 patients undergoing total hip replacement (THR) for primary (idiopathic) osteoarthrosis. Diagnosis of primary osteoarthrosis was made on the basis of clinical history, radiography, and histology of the excised femoral head. Compared to a control group of blood donors from the same geographical area there is a significant deficit of group O among the arthritic patients. It is suggested that there may be a heritable component in the susceptibility to develop osteoarthrosis in an otherwise normal hip-joint.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6614864     DOI: 10.1080/03014468300006551

Source DB:  PubMed          Journal:  Ann Hum Biol        ISSN: 0301-4460            Impact factor:   1.533


  5 in total

1.  Genetic contribution to osteoarthritis of the hip. Did ethics committee consult specialists.

Authors:  I Chambers
Journal:  BMJ       Date:  2001-05-19

2.  Association of ABO blood group with fracture pattern and mortality in hip fracture patients.

Authors:  C E Uzoigwe; R P Smith; A Khan; D Aghedo; M Venkatesan
Journal:  Ann R Coll Surg Engl       Date:  2014-09       Impact factor: 1.891

3.  Association between the ABO blood group and primary knee osteoarthritis: A case-control study.

Authors:  Changchuan Li; Nengtai Ouyang; Xiuju Wang; Anjing Liang; Yingqian Mo; Shixun Li; Junxiong Qiu; Guibin Fang; Yuan Fu; Bin Song; Zhong Chen; Yue Ding
Journal:  J Orthop Translat       Date:  2019-09-05       Impact factor: 5.191

4.  Association and Distribution of Hypertension, Obesity and ABO Blood groups in Blood Donors.

Authors:  Tulika Chandra; Ashish Gupta
Journal:  Iran J Ped Hematol Oncol       Date:  2012-09-22

5.  Relationship between the AB0 Blood System and Proximal Femoral Fracture Patterns in the Turkish Population.

Authors:  Tolgahan Kuru; Haci Ali Olcar
Journal:  Biomed Res Int       Date:  2020-03-20       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.